JAK2 V617F mutation detection

Alphabetical Test listing

JAK2 V617F mutation detection-7781

JAK2 V617F mutation detection
Janus Kinase 2
Tyrosine Kinase mutation

Detection of point mutation (G to T mutation in exon 12 resulting in the V to F amino acid change at position 617) of the human JAK2 gene. This mutation is associated with myeloproliferative disorders.


EDTA whole blood
3.0 mL

Only ONE (1) tube needs to be drawn for any combination of the following tests:

  • Calreticulin Exon 9 Assay
  • Factor V Leiden Mutation
  • Factor 2 Mutation
  • Hereditary Hemochromatosis
  • JAK2 V617F Mutation Detection
  • MTHFR C677T assay

Immediatley following collection, mix sample by inverting 8 - 10 times to prevent clotting.


Lavender (EDTA), 4mL



ACD whole blood
Sodium citrate (Na cit) whole blood
Bone marrow in EDTA
3.0 mL

Submit specimen in original collection tube, unspun


Lt blue Sodium citrate (NaCit) - 2.7mL

Yellow ACD (A or B)


Ambient (preferred)


  • Improper label (unlabeled or mislabeled)
  • Wrong container (anticoagulant or solution)
  • Improper blood/anticoagulant ratio
  • Delay in transport
  • Improper storage
  • Inappropriate timing of collection
  • Interfering substances
  • Leaking container
AHL - Molecular Diagnostics: D
7 days

Multiplex, Allele-specific Polymerase Chain Reaction (AS-PCR) analyzed by capillary electrophoresis


An interpretive report will be included


The Calreticulin Exon 9 Assay can be ordered as a reflex to a negative JAK2 V617F Mutation Detection. If ordered as a reflex, do not order the individual assay.